These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29349622)

  • 1. Transfusion practice patterns in patients with anemia receiving myelosuppressive chemotherapy for nonmyeloid cancer: results from a prospective observational study.
    Granfortuna J; Shoffner K; DePasquale SE; Badre S; Bohac C; De Oliveira Brandao C
    Support Care Cancer; 2018 Jun; 26(6):2031-2038. PubMed ID: 29349622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Questionnaire-based survey on chemotherapy-induced anemia.
    Tanaka A; Yoshino I; Makino S; Katsumata N; Takahashi K; Kuwano H; Maehara Y; Nishiyama M
    Int J Clin Oncol; 2014; 19(3):411-20. PubMed ID: 24610155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of reimbursement changes on erythropoiesis-stimulating agent utilization and transfusions.
    Hess G; Nordyke RJ; Hill J; Hulnick S
    Am J Hematol; 2010 Nov; 85(11):838-43. PubMed ID: 20976794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin Change after Red Blood Cell Transfusion for Postpartum Anemia: Secondary Analysis of a Randomized, Controlled Trial.
    Rush M; Srinivas SK; Hamm RF
    Am J Perinatol; 2024 May; 41(7):831-833. PubMed ID: 36822207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA).
    Reitan JF; Kudrik FJ; Fox K; van Breda A; Shreay S; Corey-Lisle PK
    J Med Econ; 2013; 16(5):633-8. PubMed ID: 23425291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Questionnaire-based survey on chemotherapy-induced anemia].
    Tanaka A
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):421-5. PubMed ID: 24743357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An extended maintenance dosing regimen of epoetin alfa 80,000 U every 3 weeks in anemic patients with cancer receiving chemotherapy.
    Montoya VP; Xie J; Williams D; Woodman RC; Wilhelm FE
    Support Care Cancer; 2007 Dec; 15(12):1385-92. PubMed ID: 17541653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese physician perception on the treatment of chemotherapy-induced anemia: online cross-section survey study.
    Zhang J; Du Y; Meng Y; Liu X; Mu Y
    Chin Clin Oncol; 2024 Feb; 13(1):5. PubMed ID: 38453656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Darbepoetin Alfa for Chemotherapy-induced Anemia When Initiated at Hemoglobin ≤10 g/dL.
    Pirker R; Hedenus M; Vansteenkiste J; Hernandez E; Belton L; Terwey JH
    Clin Ther; 2016 Jan; 38(1):122-135.e6. PubMed ID: 26730453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment.
    Heddens D; Alberts DS; Hannigan EV; Williams SD; Garcia D; Roe DJ; Bell J; Alvarez RD
    Gynecol Oncol; 2002 Sep; 86(3):239-43. PubMed ID: 12217742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced anemia at an urban academic medical center: iron studies and supplementation.
    Shord SS; Cuellar S
    J Am Pharm Assoc (2003); 2008; 48(4):487-93. PubMed ID: 18653424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
    Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
    J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia.
    Mel JR; Salar A; Rodríguez CA; Alegre A; González A; Cassinello J; Montesinos J; Gasquet JA; Sánchez J; Saigí E;
    Curr Med Res Opin; 2008 Oct; 24(10):2931-42. PubMed ID: 18775103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in anemia treatment among patients with five non-myeloid malignancies treated with chemotherapy in a large integrated health care delivery system in California, 2000-2013.
    Xu L; Xu H; Cannavale K; Sattayapiwat O; Rodriguez R; Page JH; Chao C
    Support Care Cancer; 2016 Jul; 24(7):2989-98. PubMed ID: 26872791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study.
    Mafodda A; Giuffrida D; Prestifilippo A; Azzarello D; Giannicola R; Mare M; Maisano R
    Support Care Cancer; 2017 Sep; 25(9):2779-2786. PubMed ID: 28391437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents.
    Mark TL; McKenzie RS; Fastenau J; Piech CT
    Curr Med Res Opin; 2005 Sep; 21(9):1347-54. PubMed ID: 16197652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and blood transfusion in elderly trauma patients.
    Loftus TJ; Brakenridge SC; Murphy TW; Nguyen LL; Moore FA; Efron PA; Mohr AM
    J Surg Res; 2018 Sep; 229():288-293. PubMed ID: 29937004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study.
    Gascón P; Rodríguez CA; Valentín V; Mata JG; Carulla J; Cassinello J; Colomer R; Baró E
    Support Care Cancer; 2013 Nov; 21(11):3039-49. PubMed ID: 23793142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to guidelines for use of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia: results of a retrospective study of an electronic medical-records database in the United States, 2002-2006.
    Luo W; Nordstrom BL; Fraeman K; Nordyke R; Ranganathan G; Linz HE; Winterkorn A; Stokes M; Ross SD; Knopf K
    Clin Ther; 2008 Dec; 30(12):2423-35. PubMed ID: 19167601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.